Showing results (31-40 of 83) with videos related to
Sort By:
Pageof 9
Bio-Medical Materials and Engineering|July 13, 2005
Ca/P mol ratio of cries-affected dentin structuresZ K Hashemi, Y Oshida, J J Deely, et al.Cornea|August 6, 2000
Comparison of antibiotic drops placed in the conjunctival cul-de-sac to antibiotic ointment applied to the lid margin in reduction of bacterial colonization on the lid marginK Hashemi, A Z Chuang, C Schweitzer, et al.British Medical Journal|October 25, 1975
Haemoglobin Rahere (beta Lys-Thr): A new high affinity haemoglobin associated with decreased 2, 3-diphosphoglycerate binding and relative polycythaemiaP A Lorkin, A D Stephens, M E Beard, et al.British Journal of Cancer|March 1, 1988
Oral urea in the treatment of secondary tumours in the liverP I Clark, M L Slevin, J A Webb, et al.Cancer Chemotherapy and Pharmacology|January 1, 1984
Delayed-release bleomycin. Comparative pharmacology of bleomycin oil suspension and bleomycin in salineM L Slevin, V J Harvey, G W Aherne, et al.Lancet (London, England)|July 8, 1978
Post-treatment laparotomy in the management of Hodgkin's diseaseS B Sutcliffe, D Katz, A G Stansfeld, et al.European Journal of Cancer & Clinical Oncology|November 1, 1985
Variable bioavailability following repeated oral doses of etoposideV J Harvey, M L Slevin, S P Joel, et al.Acta Clinica Belgica|January 1, 1989
Autoimmune haemolytic anaemia associated with malignant peritoneal mesotheliomaD L Selleslag, R J Geraghty, T S Ganesan, et al.International Journal of Clinical Pharmacology Research|January 1, 1992
Protein binding of indomethacin, methotrexate and morphine in patients with cancerR Raveendran, W M Heybroek, M Caulfield, et al.Human & Experimental Toxicology|July 1, 1992
Indomethacin and protein binding of methotrexateR Raveendran, W Heybroek, M Caulfield, et al.Pageof 9